Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls

PurposeTo investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa) in combination with recombinant human growth hormone (rhGH) in girls with central precocious puberty (CPP).MethodsClinical data of 80 girls diagnosed with idiopathic central precocious puberty (ICPP...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yuzhen Shi, Ziyi Ma, Xi Yang, Yanqin Ying, Xiaoping Luo, Ling Hou
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2022-12-01
Serija:	Frontiers in Endocrinology
Teme:	central precocious puberty gonadotropin-releasing hormone analogue recombinant human growth hormone height growth velocity predicted adult height
Online dostop:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1085385/full
Oznake:	Označite Brez oznak, prvi označite!